https://pubmed.ncbi.nlm.nih.gov/36342113/
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
Among patients with type 2 diabetes, mild-to-moderate hypertriglyceridemia, and low HDL and LDL cholesterol levels, the incidence of cardiovascular events was...
triglycerideloweringpemafibratereducecardiovascular